195 related articles for article (PubMed ID: 3317363)
1. The protection of chimpanzees against hepatitis B viral infection using a recombinant yeast-derived hepatitis B surface antigen.
Schellekens H; de Reus A; Peetermans JH; van Eerd PA
Postgrad Med J; 1987; 63 Suppl 2():93-6. PubMed ID: 3317363
[TBL] [Abstract][Full Text] [Related]
2. Persistence of vaccine-induced antibodies to hepatitis B surface antigen and the need for booster vaccination in adult subjects.
Ambrosch F; Frisch-Niggemeyer W; Kremsner P; Kunz C; André F; Safary A; Wiedermann G
Postgrad Med J; 1987; 63 Suppl 2():129-35. PubMed ID: 3317348
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of yeast-derived hepatitis B vaccines in young adults.
Bergamini F; Zanetti A
Postgrad Med J; 1987; 63 Suppl 2():137-8. PubMed ID: 3317349
[TBL] [Abstract][Full Text] [Related]
4. Reactogenicity and immunogenicity of different lots of a yeast-derived hepatitis B vaccine.
Wiedermann G; Ambrosch F; Kremsner P; Kunz C; Hauser P; Simoen E; André F; Safary A
Postgrad Med J; 1987; 63 Suppl 2():109-13. PubMed ID: 3317344
[TBL] [Abstract][Full Text] [Related]
5. Immunological properties of recombinant HBsAg produced in yeast.
Hauser P; Voet P; Simoen E; Thomas HC; Pêtre J; De Wilde M; Stephenne J
Postgrad Med J; 1987; 63 Suppl 2():83-91. PubMed ID: 2446304
[TBL] [Abstract][Full Text] [Related]
6. Reactogenicity and immunogenicity of a recombinant hepatitis B vaccine compared with a plasma-derived vaccine in young adults.
Just M; Berger R; Just V
Postgrad Med J; 1987; 63 Suppl 2():121-3. PubMed ID: 3317346
[TBL] [Abstract][Full Text] [Related]
7. Clinical development of a new recombinant DNA hepatitis B vaccine.
Safary A; André F
Postgrad Med J; 1987; 63 Suppl 2():105-7. PubMed ID: 3317343
[TBL] [Abstract][Full Text] [Related]
8. Comparative multicentre study of the immunogenicity of different hepatitis B vaccines in healthy volunteers.
Goudeau A; Denis F; Mounier M; Dubois F; Klein J; Godefroy A; Ballet M; Mountij A
Postgrad Med J; 1987; 63 Suppl 2():125-8. PubMed ID: 3317347
[TBL] [Abstract][Full Text] [Related]
9. Effects of a recombinant yeast-derived hepatitis B vaccine in healthy adults.
Scheiermann N; Gesemann KM; Kreuzfelder E; Paar D
Postgrad Med J; 1987; 63 Suppl 2():115-9. PubMed ID: 3317345
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of a yeast-derived hepatitis B vaccine (Engerix-B) in healthy young adults.
Crovari P; Crovari PC; Petrilli RC; Icardi GC; Bonanni P
Postgrad Med J; 1987; 63 Suppl 2():161-4. PubMed ID: 3317356
[TBL] [Abstract][Full Text] [Related]
11. Vaccination of newborns of HBsAg-positive carrier mothers with a recombinant DNA hepatitis B vaccine.
Cadranel S; Zeghlache S; Fernandez S; Safary A; André F
Postgrad Med J; 1987; 63 Suppl 2(736):159-60. PubMed ID: 3317355
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and tolerance of a yeast-derived hepatitis B vaccine in homosexual men.
Prinsen H; Goilav C; Safary A; André FE; Piot P
Postgrad Med J; 1987; 63 Suppl 2():147-9. PubMed ID: 3317352
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a recombinant DNA hepatitis B vaccine in neonates.
Meheus A; Alisjahbana A; Vranckx R; Sukadi A; Usman A; Ngantung W; Sugita E; Safary A; André F; Reniers J
Postgrad Med J; 1987; 63 Suppl 2():139-41. PubMed ID: 3317350
[TBL] [Abstract][Full Text] [Related]
14. Yeast-derived hepatitis B vaccine in thalassaemic patients: a preliminary report.
Giammanco G; De Grandi V; Pignato S; Dolci C; Congia M; Pisu C; De Virgiliis S
Postgrad Med J; 1987; 63 Suppl 2():151-4. PubMed ID: 3317353
[TBL] [Abstract][Full Text] [Related]
15. Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus.
Ogata N; Cote PJ; Zanetti AR; Miller RH; Shapiro M; Gerin J; Purcell RH
Hepatology; 1999 Sep; 30(3):779-86. PubMed ID: 10462386
[TBL] [Abstract][Full Text] [Related]
16. Active immunization against hepatitis B: immunogenicity of a recombinant DNA vaccine in females, heterosexual and homosexual males.
Laukamm-Josten U; von Laer G; Feldmeier H; Bienzle U; Uy A; Thomssen R; Guggenmoos-Holzmann I
Postgrad Med J; 1987; 63 Suppl 2():143-6. PubMed ID: 3317351
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of a recombinant hepatitis B vaccine in haemodialysis patients.
Bruguera M; Cremades M; Mayor A; Sánchez Tapias JM; Rodés J
Postgrad Med J; 1987; 63 Suppl 2():155-8. PubMed ID: 3317354
[TBL] [Abstract][Full Text] [Related]
18. Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine.
André FE; Safary A
Postgrad Med J; 1987; 63 Suppl 2():169-77. PubMed ID: 3317357
[TBL] [Abstract][Full Text] [Related]
19. Development of a hepatitis B vaccine from transformed yeast cells.
Pêtre J; Van Wijnendaele F; De Neys B; Conrath K; Van Opstal O; Hauser P; Rutgers T; Cabezon T; Capiau C; Harford N
Postgrad Med J; 1987; 63 Suppl 2():73-81. PubMed ID: 3317362
[TBL] [Abstract][Full Text] [Related]
20. Comparison of a bacteriophage-delivered DNA vaccine and a commercially available recombinant protein vaccine against hepatitis B.
Clark JR; Bartley K; Jepson CD; Craik V; March JB
FEMS Immunol Med Microbiol; 2011 Mar; 61(2):197-204. PubMed ID: 21204995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
